Scientists have developed a laboratory method to artificially produce curculigoside A, a compound that can be used to treat arthritis, ischemia, and osteoporosis.
According to Oxu.Az, Russia's Ministry of Education and Science announced this innovation to TASS. The natural source of this compound, the plant "Curculigo orchis," is endangered, making industrial-scale natural extraction impossible.
Researchers from Tomsk Polytechnic University (TPU), in collaboration with Swedish colleagues, have discovered the first artificial synthesis method for curculigoside A. This innovative technology is more efficient than processing natural resources and opens up broad opportunities for further biomedical research.
The compound is distinguished by its ability to slow cell death, halt inflammatory processes, and stop oxidative stress. The research team achieved a 90% efficiency in synthesizing the compound through a five-stage process. The new technology enables stable production of both the compound and its derivatives, facilitating clinical trials.
